Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00065182
Status:
COMPLETED
Last Update Posted:
2019-06-24
First Post:
2003-07-17
Brief Title:
Comparison of IV TopotecanDocetaxel to Docetaxel Alone in Second-Line Stage IIIBIV Non-Small Cell Lung Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline